Latest Biotech News

Argenx agreed to buy Forte Biosciences in a $2.2 billion cash deal, aiming to expand its immunology pipeline. The acquisition underscores continued consolidation among mid-size and larger...

Scribe Therapeutics priced an upsized $128.7 million IPO, strengthening funding for its liver-targeted gene silencing program STX-1150 and further early pipeline development. The company sold 8.58...

Industry discussions at major 2026 biotech conferences pointed to renewed deal activity, with Q1 2026 showing the highest number of deals since 2023—nearly double the level from the prior year....

A retrospective cohort analysis linked prolonged recombinant interleukin-11 (rhIL-11) therapy to cardiac effects in patients with severe thrombocytopenia. The study, published in BMC Pharmacology...

Research in Nature Metabolism reported that lipids present in ovarian cancer ascites can impair T cell activation by disrupting T cell receptor (TCR) dynamics. Instead of fitting neatly into...

A new extracellular vesicle (EV) engineering strategy published in Nature Biomedical Engineering aimed to turn EVs from generic delivery vehicles into precision “mail services.” The study...

A review focused on T-cell engagers (TCEs) highlighted how engineering choices must balance strong antitumor activity with acceptable safety. The piece emphasized a recurring design problem: in...

A genome-wide host-directed screening study identified both antiviral drug candidates and cellular signaling pathways that SARS-CoV-2 appears to exploit. Published in npj Viruses, the research...

Candid Health raised $120 million for an AI revenue-cycle management (RCM) platform, expanding investment behind software aimed at streamlining billing and care operations. The Series D round was...

Oncologists raised alarms about chemotherapy drug shortages, warning that persistent constraints on manufacturing and pricing incentives can force substitutions and workarounds. A report cited...

A Nature Communications study reports that lactic acid produced in host cells can weaken interferon (IFN) antiviral signaling, changing how innate immune cues control viral infections. The work...

Researchers report that low-frequency ultrasound can directly inhibit the migration of patient-derived oral cancer cells in vitro, pointing to a potential non-invasive therapy route for a...

A Cell Death Discovery study finds that neural stem cell exosomes can strengthen astrocyte repair programs and improve blood-brain barrier (BBB) integrity after radiation injury. Using...

Nature Metabolism reports that lipid mixtures found in ovarian cancer patient ascites can impair T-cell activation by disturbing T-cell receptor (TCR) dynamics. Instead of acting like classic...

npj Viruses reports a genome-wide host-directed screening strategy that identifies both host-targeted drug candidates and SARS-CoV-2 pro-viral cellular signaling routes. The approach shifts...

Crystalys Therapeutics secured an additional $130 million to support pivotal tests of its gout drug dotinurad, currently in late-stage pivotal development. Dotinurad is targeting a disease area...

Oncologists are raising alarms about critical chemotherapy shortages, citing disruptions that force substitutions, workarounds, and difficult patient discussions. The reported shortages include...

Candid Health raised $120 million for its AI-driven revenue cycle management platform, supporting expanded deployment of automation in coding, claims, and follow-up workflows. The Series D round...

A new study reports that cannabidiol (CBD) delivered via albumin nanoparticles improves brain delivery and protects neurons in an Alzheimer’s-focused model. The work refines a drug-delivery...

A Nature Communications 2026 trial explores whether combining low-dose baricitinib with danazol can improve outcomes for primary immune thrombocytopenia (ITP). The strategy is built around two...